KR20070083638A - 스태필로코커스 아우레우스 철포획체의 억제제에 대한스크리닝 분석 - Google Patents

스태필로코커스 아우레우스 철포획체의 억제제에 대한스크리닝 분석 Download PDF

Info

Publication number
KR20070083638A
KR20070083638A KR1020077007982A KR20077007982A KR20070083638A KR 20070083638 A KR20070083638 A KR 20070083638A KR 1020077007982 A KR1020077007982 A KR 1020077007982A KR 20077007982 A KR20077007982 A KR 20077007982A KR 20070083638 A KR20070083638 A KR 20070083638A
Authority
KR
South Korea
Prior art keywords
seq
leu
sbn
ile
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020077007982A
Other languages
English (en)
Korean (ko)
Inventor
데이비드 이. 하인리치스
수잔나 데일
Original Assignee
더 유니버시티 오브 웨스턴 온타리오
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 더 유니버시티 오브 웨스턴 온타리오 filed Critical 더 유니버시티 오브 웨스턴 온타리오
Publication of KR20070083638A publication Critical patent/KR20070083638A/ko
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering nucleic acids [NA]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/305—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Micrococcaceae (F)
    • G01N2333/31—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Analytical Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
KR1020077007982A 2004-09-08 2005-09-08 스태필로코커스 아우레우스 철포획체의 억제제에 대한스크리닝 분석 Withdrawn KR20070083638A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60789604P 2004-09-08 2004-09-08
US60/607,896 2004-09-08

Publications (1)

Publication Number Publication Date
KR20070083638A true KR20070083638A (ko) 2007-08-24

Family

ID=36203330

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020077007982A Withdrawn KR20070083638A (ko) 2004-09-08 2005-09-08 스태필로코커스 아우레우스 철포획체의 억제제에 대한스크리닝 분석

Country Status (7)

Country Link
US (1) US20110206685A1 (enExample)
EP (1) EP1786907A4 (enExample)
JP (1) JP2008512108A (enExample)
KR (1) KR20070083638A (enExample)
AU (1) AU2005297171A1 (enExample)
CA (1) CA2576643A1 (enExample)
WO (1) WO2006043182A2 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102203268A (zh) * 2008-08-19 2011-09-28 西安大略大学 细菌感染中铁载体介导的铁摄取

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994000868A1 (en) * 1992-06-26 1994-01-06 Materials Research Corporation Transport system for wafer processing line
WO2002077183A2 (en) * 2001-03-21 2002-10-03 Elitra Pharmaceuticals, Inc. Identification of essential genes in microorganisms
GB0107661D0 (en) * 2001-03-27 2001-05-16 Chiron Spa Staphylococcus aureus
AU2002353764A1 (en) * 2001-06-17 2003-03-18 D-Squared Biotechnologies, Inc. Staphylococci surface-exposed immunogenic polypeptides
US6605459B2 (en) * 2001-07-13 2003-08-12 Paradigm Genetics, Inc. Methods for measuring cysteine and determining cysteine synthase activity
US20040029129A1 (en) * 2001-10-25 2004-02-12 Liangsu Wang Identification of essential genes in microorganisms

Also Published As

Publication number Publication date
WO2006043182A3 (en) 2006-09-21
JP2008512108A (ja) 2008-04-24
US20110206685A1 (en) 2011-08-25
WO2006043182A2 (en) 2006-04-27
EP1786907A2 (en) 2007-05-23
CA2576643A1 (en) 2006-04-27
AU2005297171A1 (en) 2006-04-27
EP1786907A4 (en) 2009-01-21

Similar Documents

Publication Publication Date Title
Martínez‐Bueno et al. Analysis of the gene cluster involved in production and immunity of the peptide antibiotic AS‐48 in Enterococcus faecalis
Avilés‐Reyes et al. Cnm is a major virulence factor of invasive S treptococcus mutans and part of a conserved three‐gene locus
WO2008152447A2 (en) Staphylococcus aureus specific anti-infectives
KR20070085457A (ko) 스태필로코쿠스 아우레우스의 철에 의해 조절되는 표면결정인자 ＩｓｄＡ, ＩｓｄＢ, 및 ＩｓｄＣ 기재 백신,조성물 및 방법
KR20030003221A (ko) 대장균 증식에 필요한 유전자
US20080050361A1 (en) Staphylococcus aureas specific anti-infectives
US20040157314A1 (en) Inhibitors of Staphylococcus aureus primary sigma factor and uses thereof
KR20070083638A (ko) 스태필로코커스 아우레우스 철포획체의 억제제에 대한스크리닝 분석
JP5265188B2 (ja) Ｓｔａｐｈｙｌｏｃｏｃｃｕｓａｕｒｅｕｓにおける鉄輸送阻害剤を同定する方法
JPH10113189A (ja) 新規 ＲＮａｓｅＰ
US8729013B2 (en) Methods of inhibiting staphylobactin-mediated iron uptake in S. aureus
JPH11266880A (ja) 新規ｄｂｐＡ
JPH11235183A (ja) シグナル認識粒子ポリペプチドおよびポリヌクレオチド
JPH1198993A (ja) 新規化合物
JP2001514025A (ja) 新規ｒｎａｓｅｐ
JP4270466B2 (ja) ＮＡＤａｓｅ、ＳＮＩおよびＳＬＯ遺伝子を含むオペロンから発現するタンパク質の製造方法、それにより得られるタンパク質およびその使用
JP2004515251A (ja) スタフィロコッカス・アウレウス必須遺伝子及びそのコードされるタンパク質ｓｔａａｕ＿ｒ９に関連する組成物及び方法
JPH11285389A (ja) 新規ｆｔｓＹ
JPH11155582A (ja) 新規ＧｌｍＵ
US7271005B2 (en) Modulation of bacterial membrane permeability
US20100129349A1 (en) Methods of inhibiting staphylobactin-mediated iron uptake in S. aureus
US20070292873A1 (en) Bacterial iron acquisition targets
JP2002525048A (ja) Ｒｎａｓｅｐポリペプチド
JPH11253170A (ja) ＦｔｓＹ
CZ20002465A3 (cs) Esenciální bakteriální geny a jejich použití

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20070406

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid